Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer

Summary by Benzinga
NAARDEN, the Netherlands and STEVENAGE, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) --  Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, today announces the appointment of Dr. Katie Chapman as Chief Scientific Officer (CSO). Katie has held the position of Head of Discovery Biology since joining the Company in 2022 following a distinguished career in the pharmaceutical and biotech in…

1 Articles

BenzingaBenzinga
Center

Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer

NAARDEN, the Netherlands and STEVENAGE, United Kingdom, Oct. 01, 2025 (GLOBE NEWSWIRE) --  Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, today announces the appointment of Dr. Katie Chapman as Chief Scientific Officer (CSO). Katie has held the position of Head of Discovery Biology since joining the Company in 2022 following a distinguished career in the pharmaceutical and biotech in…

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Wednesday, October 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Naarden icon

Naarden

News
For You
SearchBlindspotLocal